• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者脑脊液细胞因子:综述与荟萃分析。

Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis.

机构信息

Emory University School of Medicine, Atlanta, GA, USA.

Children's Healthcare of Atlanta, Division of Pediatric Neurology, Emory University, 1400 Tulle Road NE, 8th Floor, Atlanta, GA, USA.

出版信息

J Neurol. 2023 Nov;270(11):5155-5161. doi: 10.1007/s00415-023-11928-3. Epub 2023 Aug 15.

DOI:10.1007/s00415-023-11928-3
PMID:37581633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10591843/
Abstract

INTRODUCTION

Neurological involvement can occur in patients with SARS-CoV-2 infections, resulting in coronavirus disease 2019 (COVID-19). Cytokine alterations are associated with neurological symptoms in COVID-19. We performed a review of cytokines in the cerebrospinal fluid (CSF) of patients with COVID-19.

METHODS

Two reviewers independently searched PubMed for all relevant articles published prior to November 11, 2022. Active SARS-CoV-2 infection and CSF cytokine analyses were required for inclusion.

RESULTS

Three-hundred forty-six patients with COVID-19 and 356 controls from 28 studies were included. SARS-CoV-2 PCR was positive in the CSF of 0.9% (3/337) of patients with COVID-19. Thirty-seven different cytokines were elevated in the CSF of patients with COVID-19 when compared to controls and the standards set forth by individual assays used in each study. Of the 37 cytokines, IL-6 and IL-8 were most commonly elevated. CSF IL-6 is elevated in 60%, and CSF IL-8 is elevated in 51% of patients with COVID-19.

CONCLUSION

Levels of several inflammatory cytokines are elevated in the CSF of patients with COVID-19, and SARS-CoV-2 PCR is often not isolated in the CSF of patients with COVID-19. Many patients with COVID-19 have neurological symptoms and given the cytokine elevations in the absence of detectable viral RNA in cerebrospinal fluid; further study of the CSF cytokine profiles and pathogenesis of neurological symptoms in COVID-19 is needed.

摘要

简介

严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染患者可出现神经系统受累,导致 2019 冠状病毒病(COVID-19)。细胞因子改变与 COVID-19 的神经系统症状相关。我们对 COVID-19 患者脑脊液(CSF)中的细胞因子进行了综述。

方法

两名审查员独立检索了截至 2022 年 11 月 11 日在 PubMed 上发表的所有相关文章。纳入标准为有活动性 SARS-CoV-2 感染且对 CSF 细胞因子进行了分析。

结果

纳入了 28 项研究中的 346 例 COVID-19 患者和 356 例对照。COVID-19 患者中有 0.9%(3/337)的 CSF 中 SARS-CoV-2 PCR 阳性。与对照和各研究中使用的检测方法设定的标准相比,COVID-19 患者的 CSF 中有 37 种不同的细胞因子升高。在这 37 种细胞因子中,IL-6 和 IL-8 最常升高。COVID-19 患者的 CSF IL-6 升高占 60%,CSF IL-8 升高占 51%。

结论

COVID-19 患者的 CSF 中几种炎症细胞因子水平升高,且 COVID-19 患者的 CSF 中通常无法分离出 SARS-CoV-2 RNA。许多 COVID-19 患者有神经系统症状,鉴于 CSF 中细胞因子升高而病毒 RNA 不可检测;需要进一步研究 COVID-19 中 CSF 细胞因子谱和神经系统症状的发病机制。

相似文献

1
Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis.COVID-19 患者脑脊液细胞因子:综述与荟萃分析。
J Neurol. 2023 Nov;270(11):5155-5161. doi: 10.1007/s00415-023-11928-3. Epub 2023 Aug 15.
2
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
3
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
4
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
7
CCL25 in the cerebrospinal fluid is negatively correlated with fatigue in chronic pain patients.慢性疼痛患者脑脊液中的CCL25与疲劳呈负相关。
Brain Behav Immun. 2025 Mar 28;128:54-64. doi: 10.1016/j.bbi.2025.03.030.
8
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
9
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

引用本文的文献

1
Long-term neurocognitive outcomes of SARS-CoV-2 infection in a hamster model.仓鼠模型中 SARS-CoV-2 感染的长期神经认知结果
Front Microbiol. 2025 Aug 14;16:1646616. doi: 10.3389/fmicb.2025.1646616. eCollection 2025.
2
What would it take to prove that a chronic infection is a causal agent in Alzheimer's disease?要如何证明慢性感染是阿尔茨海默病的致病因素呢?
Trends Neurosci. 2025 Aug;48(8):608-623. doi: 10.1016/j.tins.2025.05.009. Epub 2025 Jun 16.
3
The effects of enhanced external counter-pulsation on post-acute sequelae of COVID-19: A narrative review.

本文引用的文献

1
COVID-19 and the Pandemic-Related Aspects in Pediatric Demyelinating Disorders.COVID-19 与儿科脱髓鞘疾病相关的大流行方面。
Semin Pediatr Neurol. 2023 Jul;46:101055. doi: 10.1016/j.spen.2023.101055. Epub 2023 May 10.
2
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study.严重神经新冠与外周免疫特征、自身免疫和神经退行性变相关:一项前瞻性横断面研究。
Nat Commun. 2022 Nov 9;13(1):6777. doi: 10.1038/s41467-022-34068-0.
3
Blood-brain Barrier Damage is Pivotal for SARS-CoV-2 Infection to the Central Nervous System.
增强型体外反搏对新型冠状病毒肺炎急性后期后遗症的影响:一项叙述性综述。
Open Med (Wars). 2025 Jan 9;20(1):20241067. doi: 10.1515/med-2024-1067. eCollection 2025.
4
IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions.白细胞介素-8(CXCL8)与精神神经免疫过程及神经精神疾病的相关性。
J Pers Med. 2024 May 3;14(5):488. doi: 10.3390/jpm14050488.
5
Current clinical findings of acute neurological syndromes after SARS-CoV-2 infection.新型冠状病毒2感染后急性神经综合征的当前临床发现。
MedComm (2020). 2024 Mar 9;5(3):e508. doi: 10.1002/mco2.508. eCollection 2024 Mar.
6
SARS-CoV-2 Vaccination- or Infection-related Trigeminal Neuralgia/Radiculitis.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗接种或感染相关的三叉神经痛/神经根炎
Intern Med. 2024 Mar 1;63(5):761. doi: 10.2169/internalmedicine.3152-23. Epub 2023 Dec 18.
7
Viral Entry Inhibitors Protect against SARS-CoV-2-Induced Neurite Shortening in Differentiated SH-SY5Y Cells.病毒进入抑制剂可预防 SARS-CoV-2 诱导的分化 SH-SY5Y 细胞突起缩短。
Viruses. 2023 Sep 28;15(10):2020. doi: 10.3390/v15102020.
血脑屏障损伤是SARS-CoV-2感染中枢神经系统的关键因素。
Exp Neurobiol. 2022 Aug 31;31(4):270-276. doi: 10.5607/en21049.
4
Clinical Manifestation, Management, and Outcomes in Patients with COVID-19 Vaccine-Induced Acute Encephalitis: Two Case Reports and a Literature Review.新型冠状病毒肺炎疫苗诱导的急性脑炎患者的临床表现、管理及预后:两例病例报告及文献综述
Vaccines (Basel). 2022 Jul 31;10(8):1230. doi: 10.3390/vaccines10081230.
5
Neurological Complications in Children Hospitalized With Seizures and Respiratory Infections: A Comparison Between SARS-CoV-2 and Other Respiratory Infections.儿童因癫痫发作和呼吸道感染住院的神经系统并发症:SARS-CoV-2 与其他呼吸道感染的比较。
Pediatr Neurol. 2022 Oct;135:52-55. doi: 10.1016/j.pediatrneurol.2022.07.010. Epub 2022 Jul 30.
6
Encephalitis with status epilepticus and stroke as complications of non-severe COVID-19 in a young female patient: a case report.年轻女性非重症 COVID-19 并发癫痫持续状态和中风脑炎:一例病例报告。
BMC Neurol. 2022 Jul 11;22(1):253. doi: 10.1186/s12883-022-02782-3.
7
Cytokines and microRNAs in SARS-CoV-2: What do we know?严重急性呼吸综合征冠状病毒2中的细胞因子和微小RNA:我们了解什么?
Mol Ther Nucleic Acids. 2022 Sep 13;29:219-242. doi: 10.1016/j.omtn.2022.06.017. Epub 2022 Jun 25.
8
Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.新冠病毒感染患者伴或不伴神经系统症状与无感染或神经系统症状对照者脑脊液中的病毒抗原和炎症生物标志物比较。
JAMA Netw Open. 2022 May 2;5(5):e2213253. doi: 10.1001/jamanetworkopen.2022.13253.
9
CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome.COVID-19 相关脑病和脑炎的 CSF 生物标志物可预测长期预后。
Front Immunol. 2022 Apr 11;13:866153. doi: 10.3389/fimmu.2022.866153. eCollection 2022.
10
COVID-19-Associated Encephalopathy: Systematic Review of Case Reports.新型冠状病毒肺炎相关脑病:病例报告的系统评价
J Clin Neurol. 2022 Mar;18(2):194-206. doi: 10.3988/jcn.2022.18.2.194. Epub 2022 Feb 14.